Wang YY - Search Results

1

Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression.

Wang YY, Zhou N, Liu HS, Gong XL, Zhu R, Li XY, Sun Z, Zong XH, Li NN, Meng CT, Bai CM, Li TS. Wang YY, et al. Cancer Med. 2020 Jul;9(14):5086-5094. doi: 10.1002/cam4.3150. Epub 2020 May 27. Cancer Med. 2020. PMID: 32459060 Free PMC article.

2

[Treatment and prognosis of 77 cases of small cell lung cancer].

Shao YJ, Wang YY, Meng CT, Wang YZ. Shao YJ, et al. Among authors: wang yy, wang yz. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Aug;32(4):394-7. doi: 10.3881/j.issn.1000-503X.2010.04.007. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010. PMID: 20868596 Chinese.

3

Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer.

Li X, Zhou J, Chen S, Guan M, Wang Y, Zhao L, Ying H, Zhou Y. Li X, et al. J Int Med Res. 2014 Aug;42(4):906-14. doi: 10.1177/0300060514527058. Epub 2014 Jun 5. J Int Med Res. 2014. PMID: 24903556 Free article. Clinical Trial.

4

Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Case-Control Study.

Zhao NJ, Sun Z, Wang Y, Ning X, Jia N, Meng C, Wang Y. Zhao NJ, et al. Transl Oncol. 2014 Aug;7(4):508-12. doi: 10.1016/j.tranon.2014.05.005. Epub 2014 Jun 19. Transl Oncol. 2014. PMID: 24954357 Free PMC article.

5

Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer.

Ying H, Yang XD, Sun Z, Ning X, Wang Y, Bai C, Chen S, Wang Y. Ying H, et al. Med Oncol. 2014 Oct;31(10):220. doi: 10.1007/s12032-014-0220-4. Epub 2014 Sep 13. Med Oncol. 2014. PMID: 25216867 Clinical Trial.

6

The influence of XRCC1 genetic variants on lung cancer susceptibility in Chinese Han population.

Wang Y, Ni J, Sun Z, Chen S, Jiao Y, Bai C. Wang Y, et al. Gene. 2015 Feb 10;556(2):127-31. doi: 10.1016/j.gene.2014.11.044. Epub 2014 Nov 27. Gene. 2015. PMID: 25433331

7

ROS-mediated activation of JNK/p38 contributes partially to the pro-apoptotic effect of ajoene on cells of lung adenocarcinoma.

Wang Y, Sun Z, Chen S, Jiao Y, Bai C. Wang Y, et al. Tumour Biol. 2016 Mar;37(3):3727-38. doi: 10.1007/s13277-015-4181-9. Epub 2015 Oct 14. Tumour Biol. 2016. PMID: 26468015

8

Up regulation of IL-6 is involved in di (2-ethylhexyl) phthalate (DEHP) induced migration and invasion of non small cell lung cancer (NSCLC) cells.

Wang Y, Zhao M, Liu J, Ni J, Jiao Y, Bai C. Wang Y, et al. Biomed Pharmacother. 2017 May;89:1037-1044. doi: 10.1016/j.biopha.2017.02.107. Epub 2017 Mar 10. Biomed Pharmacother. 2017. PMID: 28292012

9

Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance.

Ni J, Weng L, Liu Y, Sun Z, Bai C, Wang Y. Ni J, et al. Oncol Lett. 2017 Jun;13(6):4549-4557. doi: 10.3892/ol.2017.6022. Epub 2017 Apr 11. Oncol Lett. 2017. PMID: 28599456 Free PMC article.

10

miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.

Wang Y, Zhao M, Liu J, Sun Z, Ni J, Liu H. Wang Y, et al. Oncol Rep. 2017 Sep;38(3):1715-1723. doi: 10.3892/or.2017.5808. Epub 2017 Jul 12. Oncol Rep. 2017. PMID: 28713974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,159 results

Search Page

Filters